Literature DB >> 19765405

Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats.

Tse-Chou Cheng1, Chian-Shiung Lin, Chih-Chieh Hsu, Li-Jen Chen, Kai-Chun Cheng, Juei-Tang Cheng.   

Abstract

Curcumin, an active principle contained in rhizome of Curcuma longa, has been mentioned to show merit for diabetes through its anti-oxidative and anti-inflammatory properties. In the present study, we found that curcumin caused a concentration-dependent increase of glucose uptake into skeletal muscle isolated from Wistar rats. This action was inhibited by pirenzepine at concentration enough to block muscarinic M-1 cholinoceptor (M(1)-mAChR). In radioligand binding assay, the binding of [(3)H]-pirenzepine was also displaced by curcumin in a concentration-dependent manner. In the presence of inhibitors for PLC-PI3K pathway, either U73122 (phospholipase C inhibitor) or LY294002 (phosphoinositide 3-kinase inhibitor), curcumin-stimulated glucose uptake into skeletal muscle was markedly reduced. In Western blotting analysis, the membrane protein level of glucose transporter 4 (GLUT4) increased by curcumin was also reversed by blockade of M(1)-mAChR or PLC-PI3K pathway in a same manner. In conclusion, the obtained results suggest that curcumin can activate M(1)-mAChR at concentrations lower than to scavenge free radicals for increase of glucose uptake into skeletal muscle through PLC-PI3-kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765405     DOI: 10.1016/j.neulet.2009.09.012

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Mitochondrial ROS-Mediated Metabolic and Cytotoxic Effects of Isoproterenol on Cardiomyocytes Are p53-Dependent and Reversed by Curcumin.

Authors:  Jin Hee Lee; Da Hae Kim; MinA Kim; Kyung-Ho Jung; Kyung-Han Lee
Journal:  Molecules       Date:  2022-02-16       Impact factor: 4.411

2.  Curcumae Radix Decreases Neurodegenerative Markers through Glycolysis Decrease and TCA Cycle Activation.

Authors:  Seong-Lae Jo; Hyun Yang; Sang R Lee; Jun H Heo; Hye-Won Lee; Eui-Ju Hong
Journal:  Nutrients       Date:  2022-04-11       Impact factor: 6.706

3.  Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).

Authors:  Vânia Ortega Gutierres; Michel Leandro Campos; Carlos Alberto Arcaro; Renata Pires Assis; Helen Mariana Baldan-Cimatti; Rosângela Gonçalves Peccinini; Silvia Paula-Gomes; Isis Carmo Kettelhut; Amanda Martins Baviera; Iguatemy Lourenço Brunetti
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-03       Impact factor: 2.629

Review 4.  Effects of curcumin on ion channels and transporters.

Authors:  Xuemei Zhang; Qijing Chen; Yunman Wang; Wen Peng; Hui Cai
Journal:  Front Physiol       Date:  2014-03-11       Impact factor: 4.566

Review 5.  Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin.

Authors:  Zeinab Ghorbani; Azita Hekmatdoost; Parvin Mirmiran
Journal:  Int J Endocrinol Metab       Date:  2014-10-01

6.  Olive Leaf Polyphenols (OLPs) Stimulate GLUT4 Expression and Translocation in the Skeletal Muscle of Diabetic Rats.

Authors:  Jasminka Giacometti; Damir Muhvić; Tanja Grubić-Kezele; Marina Nikolić; Tamara Šoić-Vranić; Snježana Bajek
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 7.  Curcumin and diabetes: a systematic review.

Authors:  Dong-Wei Zhang; Min Fu; Si-Hua Gao; Jun-Li Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-24       Impact factor: 2.629

Review 8.  Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus.

Authors:  Aminu Mohammed; Md Shahidul Islam
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

9.  Impact of curcumin treatment on diabetic albino rats.

Authors:  Najlaa Bint Saud Al-Saud
Journal:  Saudi J Biol Sci       Date:  2019-12-02       Impact factor: 4.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.